Related by context. All words. (Click for frequent words.) 63 PROMETHEUS 62 DA VINCI 61 STUDY RESULTS 61 STENT 60 IN PATIENTS WITH 60 ILLUSTRATE 60 RADIANT 60 ASTEROID 60 PHASE III 60 Initiated Phase 60 PHASE II 59 MOLECULAR 59 CABANA 59 Angiotensin Converting Enzyme 59 DIAGNOSTIC 58 ANTIBODY 58 BLOSSOM 58 PARKINSON 'S DISEASE 58 STARSHIP 58 DUROS 57 VASCULAR 57 Randomized controlled 57 phase IIIb 57 Clin Oncol 57 multicenter randomized controlled 57 EVENING WITH 57 Safinamide 57 FOR TREATMENT 57 multicentre randomized 57 CABERNET 57 Novel Inhibitor 57 Trandolapril 57 PRELUDE 56 SORT OUT 56 randomized multicenter 56 SHUN 56 Prospective Randomized 56 abstr 56 Sirolimus eluting 56 Tyrosine Kinase Inhibitor 56 USA UroToday.com 56 label multicenter Phase 56 PEG IFN 56 CARDIOLOGY 56 RE MODEL 56 BLOOD SUGAR 56 NSABP B 55 Randomized Evaluation 55 EVIDENCE OF 55 ADVANCES IN 55 CANCER PATIENT 55 Oral Insulin 55 IS EXPECTED TO PRODUCE 55 ATTRACT 55 ADVANCE REVIEW 55 Observational Study 55 #:#-# [001] 55 REFLEX 55 Pharmacodynamic 55 Risk Stratification 55 GETS GREEN LIGHT 55 Randomised 55 THERAPEUTICS 55 Ziprasidone 55 CATANIA 55 Glatiramer Acetate 55 See CLINICAL PHARMACOLOGY 55 INSTRUMENTS 55 STRAVINSKY 54 RE LY trial 54 TREASURES OF 54 GOVERNOR OF 54 DO NOT EMAIL 54 FEATURED AT 54 FOR BREAST CANCER 54 DISORDERS 54 prospective multicenter 54 renal artery stenting 54 CHOIR OF 54 Degarelix 54 LIFE SCIENCE 54 GROWS IN 54 Aflibercept 54 DEFER 54 Phase 2b Study 54 TOP SEEDS 54 NIGHT WITH 54 pan HDAC inhibitor 54 Schizophrenia Treatment 54 REIGN IN 54 Treatment Outcome 54 humanized monoclonal 54 CARILLON 54 receptor modulators 54 LISTED IN 54 Cardiac Allograft Rejection 54 FEMALE WAS 54 #:#-# [006] 54 multicenter phase 53 ASST 53 Aptamer 53 IMPLANT 53 multicenter Phase II 53 Cardiotoxicity 53 TECHNOLOGIST 53 BECKONS FOR 53 Aurora Kinase 53 MINDSET 53 Sipuleucel T 53 OPTS FOR 53 SISTERS OF 53 VASSALLO 53 subanalysis 53 selective adenosine 53 THE METROPOLITAN OPERA 53 Pharmaceuticals Initiates 53 ONCOLOGY 53 PLASTER 53 M. MELENDEZ 53 CATHEDRAL OF 53 SYMPOSIUM ON 53 PREMIERES 53 AMERICAN MEDICAL 53 dimeglumine 53 Percutaneous Tibial Nerve Stimulation 53 EMBLEM 53 Prospective Multicenter 53 PICASSO 53 Podium Presentation 53 WORCESTER PREP 53 Pertuzumab 53 Intervention Trial 53 Calcium Acetate 53 BIENNIAL 53 Diastolic Heart Failure 53 YEARS LATER 53 ALLERGAN 53 CELEBRATED IN 53 DIAGNOSTICS 53 BLOSSOMS 53 GLORY FOR 53 SILVER JUBILEE 53 controlled multicenter Phase 53 RE LY 53 PREDICTIVE 52 THE LAST DAYS 52 Echocardiographic 52 Targeted Therapy 52 DONATO 52 CORPORATION ANNOUNCES 52 SYMPHONY 52 Temsirolimus 52 SENSORS 52 TRANSFORMS 52 everolimus eluting 52 INSTITUTE OF 52 AMENDMENT TO THE 52 SERIAL NUMBER 52 BIOSCIENCES 52 HEADING BACK TO 52 Deforolimus 52 Parathyroid Hormone 52 THROUGH MAY 52 IS MOVING TOWARD THE 52 Anticancer Drug 52 Pharmacokinetic Study 52 LABORATORY 52 FUNDRAISER FOR 52 Alkaline Phosphatase 52 Virtual Histology 52 COGENT 52 Receptor Agonist 52 Kinase Inhibitor 52 WEDNESDAY NIGHT AND 52 Cannabinoid 52 LIFE SCIENCES 52 CELEBRATES #TH ANNIVERSARY 52 YOUNG PEOPLE 'S 52 PHARMACEUTICALS INC 52 PIANO TRIO 52 HER RESIDENCE 52 Kinase Inhibitors 52 WIND SYMPHONY 52 PHOTOS COURTESY OF 52 Confirmatory Phase 52 ADVANCE FOR 52 OUSTS 52 Abciximab 52 COURTESY OF THE 52 PROMS 51 GW# [003] 51 Carotid 51 BAHADUR 51 AND MRS 51 epoetin zeta 51 FOR WORLD CUP 51 ATMOSPHERIC 51 KIMI 51 uricase 51 GOLDEN JUBILEE 51 Preclinical Study 51 Potent Inhibitor 51 Clinical Outcome 51 Sustained Efficacy 51 TO LAUNCH NEW 51 FIBER OPTIC 51 Remission Maintenance 51 DEBUTS IN 51 gefitinib Iressa 51 ExTRACT TIMI 51 POKER TOURNAMENT 51 NN# [001] 51 Phase IIA 51 pregabalin Lyrica 51 pharmacokinetic PK study 51 Fulvestrant 51 OUT UNTIL 51 WAS ABOUT 51 ASCOT 51 transurethral 51 SHRINERS 51 Olmesartan 51 THE FIRST ANNUAL 51 ON FEB 51 ARTIST SERIES 51 Optical Coherence Tomography 51 MESSAGE FROM 51 FRIDAY NOV 51 BUNKER 51 EMAIL AND 51 Endarterectomy 51 CONTINUES IN 51 Multiple Ascending Dose 51 Transdermal Patch 51 OPENS AT 51 NEWS RELEASES 51 YET TO 51 TAKES CHARGE 51 efavirenz EFV 51 MORE THAN TREAS 51 CRASHES IN 51 COMMENCES 51 OF DESPAIR 51 PDE4 inhibitor 51 Pharmacokinetic PK 51 prospective multicentre 51 UPSET IN 51 OUR BELOVED 51 HOLLY GROVE 51 IMPRESSIVE IN 50 Sirolimus Eluting Stent 50 ARRIVES AT 50 oral treprostinil 50 OBJECTIVES 50 NIGHT CLUB 50 % MOUNTRAIL #/#-# 50 Intra operative 50 Epithelial Cell 50 Inhaled Corticosteroids 50 Aortic Dissection 50 SUNDAY JAN 50 DOO WOP 50 PLANNED FOR 50 BLUE KU 50 ASCO abstract 50 STRING QUARTET 50 TO REOPEN 50 Bioavailability 50 Carotid Artery Stenting 50 AstraZeneca Targacept 50 Zenvia Phase III 50 CAPSULES 50 SUNDAY AUG 50 UNVEILS NEW 50 CRUISES TO 50 GENOMICS 50 PROJECTOR 50 observational cohort study 50 BOW TO 50 Epirubicin 50 T. BERRY 50 clevidipine 50 THEATRES 50 ZITHROMAX 50 Biomarker Study 50 Conjugate 50 Main Outcome Measure 50 DRILL RESULTS 50 COURSE FOR 50 BEGINS IN 50 FDA Approvals 50 Muraglitazar 50 Left Ventricular 50 Anticancer Agent 50 radioligand 50 Subgroup Analysis 50 Stakeholder Opinions 50 Echocardiogram 50 MR Angiography 50 ORCHESTRA OF 50 annexin 50 Angiographic 50 neuronal nicotinic receptor NNR 50 THURSDAY OCT 50 Silodosin 50 #TH ANNIVERSARY [002] 50 SCENES FROM THE 50 Febuxostat 50 HealthTech Wire News 50 Receptor Antagonists 50 LAUNCHES IN 50 METHOD FOR 50 Valsartan 50 pharmacodynamic PD 50 Bucindolol 50 CAPRA 50 Protein Kinase 50 POSTPONED UNTIL 50 INKS 50 URGENT WINTER WEATHER MESSAGE 50 LISTING OF 50 Fibrinogen 50 HDAC Inhibitor 50 OF IRELAND 50 Escitalopram 50 CLEARS 50 Presents Preclinical Data 50 TO MONITOR 50 ARRIVES IN 50 hPTH #-# 50 Bioequivalence 50 AFFAIRS MINISTER 50 Transdermal Delivery 50 HIGHER ON 50 SPOILERS FROM 50 HepaSphere 50 Percutaneous Transluminal Coronary Angioplasty 50 PINPOINT 50 Hepatic Encephalopathy 50 BMS # 49 Carotid Stenting 49 Orally Active 49 thalidomide Thalomid 49 YOU CAN BE 49 PET tracer 49 Locked Nucleic Acid LNA 49 'S #TH ANNIVERSARY 49 2ND ADD 49 Radiation Induced 49 UNIV 49 DCCR 49 REVISE 49 prospective multicenter study 49 X RAY 49 Successfully Completes Phase 49 FLIGHT RESTRICTIONS 49 SHOW THEIR 49 TRAVELS TO 49 HEARING IN 49 PROCEDURE 49 ray fluorescence 49 THE FATE OF 49 CHAMBER SINGERS 49 Adenoscan R 49 MARVELS 49 PROCEEDINGS OF 49 Ischemic 49 TO ARRIVE IN 49 STRIKES IN 49 WEST AFRICAN 49 MEDICAL SERVICES 49 Lung Cancer Trial 49 Lucanix 49 HONOURED IN 49 Novel Therapeutic 49 MICROPHONE 49 Multicenter Phase 49 END OF 1st 49 Preclinical Models 49 ALARM N 49 ELANA 49 Cardiopulmonary bypass 49 WILL RISE 49 VentiRx Pharmaceuticals 49 adenosine injection 49 GOOD MORNING TURKEY PRESS 49 Drug Eluting Stents 49 Cancer Res 49 Sapacitabine 49 Relapsing Remitting Multiple Sclerosis 49 Analytical Tool 49 Randomized Study 49 HUTT 49 DROPS TO 49 Psychodynamic 49 LEADS IN 49 AND CRAFT FAIR 49 nitric oxide donating prostaglandin 49 Nasdaq ACHN 49 DEVELOPMENT PROJECT 49 Files IND 49 Contrast Enhanced 49 MOUNT ST 49 DOUG 'S 49 abs-cbnNEWS.com/Newsbreak #/#/# #:# 49 serotonin reuptake inhibitor 49 AN EXHIBIT 49 Initiates Phase 2b 49 OPENS NEW 49 MINI ME 49 XIENCE TM 49 Protein Expression 49 WEDNESDAY FEB 49 ELLIOTT WAVE 49 F FDG PET 49 HARMONIC 49 multicenter multinational 49 STRIDE PD 49 elotuzumab 49 IN WESTERN 49 seliciclib CYC# 49 ENDEAVOR 49 PEOPLE NEWS 49 Brain Metastases 49 HCV SPRINT 49 Coronary Arteries 49 RezularTM 49 aminolevulinic acid 49 Annexin 49 Mechanistic 49 FRESENIUS 49 PROPRIETARY 49 THROUGH SUNDAY 49 EXPLORATION PROGRAM 49 GALERIE 49 Vildagliptin 49 ANNUAL FESTIVAL 49 Randomized Controlled Trials 48 i NOTIFICATION OF 48 EXPLOSION IN 48 BURGLARY VEHICLE 48 TALKS ON 48 RESULTS FROM 48 Symptom Scale 48 BEATEN IN 48 ACHIEVES 48 Cardiopulmonary Bypass 48 Myocardial Perfusion 48 TIMP 1 48 By ERIC CARPENTER 48 Non Responders 48 Intraocular 48 selective estrogen receptor modulator 48 urography 48 Phase III Clinical Trials 48 Dose Escalation 48 DUE IN 48 NEXT STOP 48 SPECT Single Photon 48 Pharmacogenetic 48 Estrogen Receptor 48 Tenormin 48 Nasdaq IDRA today 48 NEW COURSE 48 Myocardial 48 ITHACA COLLEGE 48 Systolic Blood Pressure 48 Nicotine Vaccine 48 PROactive Study 48 Confocal 48 preclinical efficacy 48 GISSI 48 CORSAIR 48 Iloperidone 48 DOORS OPEN 48 multicentre 48 Initiates Clinical Trial 48 PEGylated interferon 48 YOUR WINNING BID 48 2ND ANNUAL 48 ON NOVEMBER 48 MEETING IN 48 SATURDAY JAN 48 LUX Lung 48 TRUS 48 Recombinant Human 48 TRAINING COURSES 48 multicentre phase 48 Protelos R 48 IN STORES 48 RE LY ® 48 PLAT 48 pharmacodynamic effects 48 AurSCOPE 48 Treating Chronic 48 Extended Release tablets 48 Completes Patient Enrollment 48 3rd edn 48 Microwave Ablation System 48 Functional Assessment 48 CALGB 48 PROactive study 48 Reperfusion 48 Oligonucleotides 48 Mutational 48 INTERNATIONAL CHILDREN 'S 48 SLATED FOR 48 Cardiovascular Outcomes 48 AV MC# 48 PAINTINGS OF 48 Myocardial Infarction 48 Vasculature 48 SALISBURY SCHOOL 48 TUESDAY MARCH 48 Subtypes 48 GEMS TM 48 WEDNESDAY SEPT 48 BIRDS OF 48 EXECUTIVE SUMMARY 48 NOD FOR 48 LIMITED ANNUAL REPORT 48 serotonin norepinephrine reuptake inhibitor 48 Histopathologic 48 SCHERING PLOUGH 48 RETHINKING 48 Randomized phase 48 Statistically Significant 48 STRATEGY FOR AN OPEN 48 PHOTOGRAPHS OF 48 SuperAntibody 48 LINKS WITH 48 EVENTS IN 48 MONDAY SEPT 48 BUSINESS TRAVEL CONSULTANT 48 Ambrisentan 48 STREP 48 DEV DA TOMAR NEXT 48 Vidaza azacitidine 48 Medicsight CAD 48 Neuroprotective Effects 48 Myocardial Perfusion Imaging 48 MONDAY JAN 48 MEVACOR 48 Therapeutic Competitors Report 48 RESOURCE FOR 48 TELSTAR 48 BANNED IN 48 JOHNS HOPKINS 48 LB# [003] 48 Prognostic Value 48 Rating Scale BPRS 48 xCELLigence System 48 Pemetrexed 48 ULTRASOUND 48 SSAO 48 Drug Eluting Balloon 48 TUESDAY AUGUST 48 SWEETIE 48 Boniva ibandronate 48 Cardiogenic Shock 48 Neoadjuvant Chemotherapy 48 Microdosing 48 FLOWER SHOW 47 SHAKESPEARE FESTIVAL 47 Particle Size Analyzer 47 GETS READY FOR 47 Content Outline 47 Asthma COPD 47 Conductive Keratoplasty 47 Akebia Therapeutics 47 VEHICLE SALES 47 LAUNCHED IN 47 CONSORT 47 lovastatin Mevacor 47 Septic Shock 47 SHOWDOWN IN 47 UNI XC 47 Chronic Pelvic Pain 47 fluorodeoxyglucose positron emission tomography 47 Antiepileptic Drug 47 Calbiochem 47 oral renin inhibitor 47 Demonstrated Significant 47 HORIZONS AMI 47 Randomized Clinical Trials 47 ROSE Y. 47 OLYMPIC TORCH 47 MACHINE GUN 47 HOSPITAL IN 47 FRIDAY MARCH 47 Vitaxin 47 Phenotypic 47 Ischaemic 47 SF #v# 47 Radiofrequency Ablation 47 Artificial Pancreas 47 GLOBAL MARKET 47 NOSE 47 LEADERS IN 47 Cilostazol 47 FRIDAYS AT 47 Guanilib 47 Lower Limb 47 EM BS 47 SEEN IN 47 Cinacalcet HCl 47 Pazopanib 47 Homeostasis 47 LOOKING AHEAD TO 47 STAFF REPORT 47 ENTERTAINMENT EDITOR 47 Suicidality 47 intracoronary 47 #F FDG PET 47 Investigational Compound 47 Sequenced Treatment Alternatives 47 ‰ ¥ 47 PHARMACEUTICALS 47 Erythropoietic 47 JAK Inhibitor 47 Insulin Glargine 47 Myocardial Ischemia 47 Anti CD# Antibody 47 JEWELRY SHOW 47 Forward Looking IVUS 47 Analogs 47 DANCE THEATRE 47 EXPANDS TO 47 MINERALS INC. 47 'S RALLY 47 BEER FESTIVAL 47 Initiates Phase III 47 Interferon Alfa 47 CAPITAL DISTRICT 47 SUNDAY JANUARY 47 etanercept Enbrel 47 Progenitor Cells 47 Protein Biomarker 47 POLICE REFORM 47 Immune Therapy 47 OPENS IN 47 Achieves Primary Endpoint 47 Protease Inhibitors 47 Finacea 47 Presents Positive 47 Anti Tumor 47 Detection Device 47 CONFERENCE IN 47 MAJOR INTERESTS IN SHARES 47 CONCERT BAND 47 RESCHEDULED FOR 47 EGS# 47 TRIUMPHS IN 47 Anthropometric 47 keratoplasty 47 Lifestyle Intervention 47 MANDALAY BAY 47 semiquantitative 47 WEDNESDAY MARCH 47 COMMUNITY EVENTS 47 Solid Tumors 47 Retinal Vein Occlusion 47 SURGICAL 47 Betaferon R 47 JOHN VIANNEY 47 UNREST IN 47 Imaging BSGI 47 Antifungals 47 ELECTS 47 proteasome inhibitor 47 Oxybutynin 47 Coronary Tree 47 Investigational Agent 47 Ticagrelor 47 Stable Angina 47 Microstructural 47 Diagnostic Criteria 47 Fluconazole 47 Intravenous Equipment 47 GUGGENHEIM MUSEUM 47 Muscarinic 47 SHOPPING MALL 47 Primary endpoints 47 pharmacophore 46 CupPrint R 46 Angiogenic 46 JERRY LYNN 46 plasma pharmacokinetics 46 Reproducibility 46 THURSDAY DEC 46 LEAVES FOR 46 Clinical Significance 46 COMPOSITE 46 viral kinetics 46 CARTO R 46 ORTH 46 Molecular Mechanisms 46 RELOVAIR ™ 46 No Observed Adverse 46 UNDERWRITERS 46 HOLE NO 46 Randomized Trial 46 safety tolerability pharmacodynamics 46 PROTONIX 46 PLANTS IN 46 BALF 46 Fasting Glucose 46 Syllego system 46 Cardiac CT 46 MIST 46 UNION COLLEGE 46 J Cardiovasc 46 CENTRAL HARDIN 46 PARTY FOR 46 PathVysion 46 PFIZER INC 46 radiofrequency RF ablation 46 AOD# [002] 46 LIAN 46 Gastrointestinal Stromal Tumors 46 peginterferon alpha 46 PRECINCT 46 STEPHEN 'S 46 BALLET 'S 46 PROGRAMME FOR 46 CAPITAL OF 46 #F FDG PET CT 46 BOUND FOR 46 Referenced EEG 46 Vascular Wrap TM 46 Prognostic 46 Etiology 46 FDA Okays 46 Immunoassay Systems 46 Benign Prostatic Hyperplasia 46 'S FAVOURITE 46 BEGINNING AT 46 QUARTZ 46 PF # [002] 46 Magnetic resonance 46 Neurobiological 46 BOROUGH OF 46 computed tomographic 46 ROCKET AF 46 MARKET OUTLOOK 46 ELISA kit 46 Initiates Clinical 46 ATTACK IN 46 WAS BORN IN 46 STATE DEPT 46 Guided Focused Ultrasound 46 phase IIb trial 46 ASIAN PACIFIC 46 INFECTIOUS DISEASE 46 NanoCrystal 46 Systemic Delivery 46 Figure S4 46 Nasdaq SHPGY 46 Avian Influenza Vaccine 46 Brief Psychiatric 46 OVER CENTRAL 46 Antipsychotic 46 Sanvar 46 MADAN 46 SPORTS STAFF 46 DOSAGE AND ADMINISTRATION 46 HOUSING PROJECT 46 EVENTS FOR 46 EXHIBITS AT 46 IMAGING 46 LARUE COUNTY 46 PROMENADE 46 Synaptic Plasticity 46 Analytical Biochemistry 46 Novel Approach 46 Metastatic Renal Cell Carcinoma 46 Pivotal Trials 46 Small Molecules 46 Epoetin 46 HMQ MT 46 Molecular Mechanism 46 Hypercholesterolemia 46 CT Angiography 46 Sustained Release 46 Optical Coherence Tomography OCT 46 Roche Boniva 46 METHODS 46 SUMMERFEST 46 Menstrual Pain 46 trastuzumab emtansine T DM1 46 Valdoxan 46 Tumor Response 46 IVER 46 FRIDAY JANUARY 46 CORP BHD 46 Drug Shows Promise 46 RISES IN 46 Imaging Techniques 46 Migraine Drug 46 Glycosylation 46 Inflammatory Pain 46 RE SURGE 46 Breast Specific 46 transesophageal 46 Elagolix 46 ASCO Abstract 46 INSISTS ON 46 VeriStrat 46 PAYMENT PLEASE PAY WITHIN 46 Zoloft sertraline 46 Coronary angioplasty 46 Clinical Trials Review 45 balloon dilation 45 ECG gated 45 FLIES TO 45 Receives Approvable Letter 45 Rebif ® 45 DELEGATION VISITS 45 basal insulin analogue 45 TRAINING IN 45 Relieve Depression 45 myocardial revascularization 45 Nucleoside 45 Bazedoxifene 45 CREATORS 45 Diasome 45 Fibrin Patch 45 TO PERFORM IN 45 #TH ANNIVERSARY OF [002] 45 NICE SUGAR 45 Topoisomerase 45 pharmaco 45 MINING COMPANY 45 mCi 45 SUTENT ® 45 motesanib diphosphate 45 PANSS Positive 45 Main Outcome Measures 45 #TH JULY 45 GATHER IN 45 Vernakalant 45 SPIRIVA ® 45 Wellbutrin Effexor 45 transvaginal sonography 45 Demonstrates Potential 45 Small Molecule 45 Tomography SPECT 45 ASSAY RESULTS 45 Tumor Targeting 45 NSCLC tumors 45 Venlafaxine 45 Therapeutic Antibody 45 Screening Tool 45 Clinical Relevance 45 Danazol 45 transabdominal 45 Submits NDA 45 Positron Emission 45 TO ELECT 45 Vimpat lacosamide 45 EMBARGOED UNTIL 45 Pralatrexate 45 HOTEL IN 45 photodynamic therapy PDT 45 TIMP 45 WEDNESDAY FEBRUARY 45 IN FIRST ROUND 45 INTERNATIONAL FILM FESTIVAL 45 Lung Cancer Drug 45 ON OCTOBER 45 WEDNESDAY JAN 45 RYLAND 45 EPA STR 45 CHIA 45 fluorescein angiography 45 Glatiramer acetate 45 PHILHARMONIC ORCHESTRA 45 BNA INFORMATION MINISTER 45 SAR# [002] 45 PM CST THIS AFTERNOON 45 GROUP STAGE 45 Systematic Approach 45 Efficacious 45 ANTIQUES SHOW 45 Maximum Tolerated Dose MTD 45 Actonel risedronate 45 :#:# 45 Regression Analysis 45 TO NOON 45 Aposense 45 orally disintegrating 45 MLN OPTION 45 RESOLOR 45 CONCERT IN 45 Darusentan 45 Metabolomic 45 STICH trial 45 Pressure Monitoring 45 GlaxoSmithKline Requip 45 Carfilzomib 45 SIGNS AGREEMENT WITH 45 Efficacy Study 45 MONDAY DEC 45 CENTRAL SCHOOL DISTRICT 45 AP Photo MOJR# 45 Holter Monitoring 45 florbetaben 45 tomography scans 45 EQ 5D 45 Cognitive Function 45 Signaling Pathways 45 Protein Interactions 45 THE PURPLE 45 Zemplar Capsules 45 Effective Treatments 45 BUT SINCE 45 GSK# [002] 45 IN JULY 45 Automated Breast Ultrasound 45 PharmaVitae 45 ViroPharma NASDAQ VPHM 45 BROADEN 45 Postmenopausal Hormone Therapy 45 PETROLEUM LIMITED 45 DEPT 45 intravitreal implant 45 photon laser 45 Interferon alfa 45 Zybrestat 45 DE LA SALLE 45 CRIMSON 45 Arisaph 45 Clinical Trial Data 45 Clin Trials 45 Novel Therapies 45 Clinical Trial Enrollment 45 Angiotensin converting enzyme ACE 45 STRUCTURE 45 OvaRex R 45 rxRNA 45 Study Shows Significant 45 ON JANUARY 45 CryoPlasty 45 Cell Adhesion 45 LUMINATE 45 Transoral 45 Femtosecond 45 Prolexys 45 SCANNING 45 Nerve Cell 44 PresbyLens ® 44 BRILINTA 44 Locus Pharmaceuticals 44 KITTS SEPTEMBER 44 Watchful Waiting 44 SAMPLES 44 Prozac fluoxetine 44 ON SEPTEMBER 44 Fine needle aspiration 44 Localized Prostate Cancer 44 teriflunomide 44 Treatment Outcomes 44 Therapeutic Competitors companiesandmarkets.com adEgemonye 44 miRview meso 44 SUPER SERIES 44 UNIVERSITY STUDENTS 44 AMBASSADOR TO 44 Hepatocellular Carcinoma 44 THAM 44 SMALL WORKS 44 Macroscopic 44 LIVE FROM 44 ECLS 44 ELISHA 44 TO LEAVE FOR 44 Placebo Effect 44 Solid Tumours 44 SIR Spheres 44 Protein Synthesis 44 Electron beam 44 transesophageal echocardiography 44 TECNIS ® 44 Oxytrol R 44 HOCKEY TEAM 44 vildagliptin 44 INTERNATIONAL CONVENTION 44 Homology 44 isoform selective 44 Correlative 44 Marqibo TM 44 INSURANCE GROUP 44 antiplatelets 44 RALLY IN 44 Pancreas Cancer 44 Excimer Laser 44 GEARS UP 44 TWO MAJOR 44 Maxalt 44 Neuroanatomy